This 2018 trial, funded by Virta Health, tested the impact of a high-compliance ketogenic diet on cardiovascular and lipid outcomes in Type 2 diabetics. Over one year, during which subjects were largely compliant with the ketogenic diet, 262 subjects in aggregate saw significant shifts away from atherogenic dyslipidemia via lipoprotein profile. This trial suggests the vast majority of diabetic subjects do not see an increase in cardiovascular risk and may see a decrease, depending on the specific markers used to assess risk.